| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.0000014587.66321.B4 |
| P698 | PubMed publication ID | 12006391 |
| P50 | author | Jason Lee Johnson | Q43990039 |
| Helen Williams | Q63620267 | ||
| P2093 | author name string | Christopher Langdale Jackson | |
| Kevin George Stephen Carson | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | knockout mouse | Q1364740 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 788-792 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice | |
| P478 | volume | 22 |
| Q36710876 | 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis |
| Q37687153 | 11β-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-/- mice |
| Q36683029 | A new murine model of stress-induced complex atherosclerotic lesions |
| Q57740341 | Acute coronary syndromes, plaque vulnerability,and carotid artery disease |
| Q35063642 | Adiponectin receptor 2 deficiency results in reduced atherosclerosis in the brachiocephalic artery in apolipoprotein E deficient mice |
| Q35088381 | Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficien |
| Q46885968 | Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development |
| Q38218391 | Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression |
| Q41886031 | Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. |
| Q36070404 | Atherosclerosis imaging: intravascular ultrasound |
| Q34248316 | Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- mice |
| Q46087953 | Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice |
| Q33598894 | Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway |
| Q49788067 | Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery |
| Q35235764 | CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism |
| Q37681518 | Cervical Rotatory Manipulation Decreases Uniaxial Tensile Properties of Rabbit Atherosclerotic Internal Carotid Artery |
| Q37368729 | Collagens in the progression and complications of atherosclerosis |
| Q33635135 | Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. |
| Q35914754 | Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis |
| Q50698610 | Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice. |
| Q34712302 | Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex. |
| Q35062347 | Coronary arterial remodeling: from bench to bedside |
| Q42782299 | Developing a novel rabbit model of atherosclerotic plaque rupture and thrombosis by cold-induced endothelial injury |
| Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
| Q28395115 | Diesel exhaust particulate increases the size and complexity of lesions in atherosclerotic mice |
| Q30406302 | Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels |
| Q28480590 | Doxycycline stabilizes vulnerable plaque via inhibiting matrix metalloproteinases and attenuating inflammation in rabbits |
| Q42876189 | Effect of Qingre Quyu Granule (清热祛瘀颗粒) on stabilizing plaques in the brachiocephalic artery of apolipoprotein E deficient mice |
| Q50992216 | Effect of minocycline on carotid atherosclerotic plaques. |
| Q33870355 | Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse |
| Q35741094 | Effects of Smad decoy ODN on shear stress-induced atherosclerotic ApoE-/-mouse. |
| Q36330116 | Effects of p53-knockout in vascular smooth muscle cells on atherosclerosis in mice |
| Q46368325 | Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis |
| Q37390765 | Emergence of targeted molecular imaging in atherosclerotic cardiovascular disease |
| Q41174875 | Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model |
| Q46553130 | Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma |
| Q47554675 | Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice |
| Q92644590 | Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE-/- mice |
| Q37724036 | Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice |
| Q30429015 | Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice |
| Q34124857 | Haemin-enhanced expression of haem oxygenase-1 stabilizes erythrocyte-induced vulnerable atherosclerotic plaques |
| Q34377261 | Haemodynamical stress in mouse aortic arch with atherosclerotic plaques: Preliminary study of plaque progression. |
| Q37330179 | Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout Mice |
| Q34021005 | Identifying novel genes for atherosclerosis through mouse-human comparative genetics |
| Q27318329 | In Vivo Mapping of Vascular Inflammation Using Multimodal Imaging |
| Q37370224 | Inflammation and plaque vulnerability |
| Q52867583 | Insulin decreases atherosclerotic plaque burden and increases plaque stability via nitric oxide synthase in apolipoprotein E-null mice. |
| Q41638983 | Investigation of RNA interference suppression of matrix metalloproteinase-9 in mouse model of atherosclerosis. |
| Q45845227 | Lentivirus-mediated RNA interference of chymase increases the plaque stability in atherosclerosis in vivo |
| Q34236802 | Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice |
| Q36924398 | Mast cells in vulnerable atherosclerotic plaques--a view to a kill. |
| Q48297988 | Metabolic profiling of murine plasma reveals eicosapentaenoic acid metabolites protecting against endothelial activation and atherosclerosis. |
| Q28070313 | Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models |
| Q36766171 | Mouse models for studies of cardiovascular complications of type 1 diabetes |
| Q30238973 | Mouse models of atherosclerosis: a historical perspective and recent advances. |
| Q36607821 | Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems |
| Q38000174 | Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability? |
| Q30482901 | Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels |
| Q36538364 | Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies |
| Q53540997 | Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques. |
| Q35151273 | Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque |
| Q41838948 | Phenotypic high-throughput screening in atherosclerosis research: focus on macrophages |
| Q87400780 | Probucol via inhibition of NHE1 attenuates LPS-accelerated atherosclerosis and promotes plaque stability in vivo |
| Q44776898 | Radiation-induced atherosclerotic plaque progression in a hypercholesterolemic rabbit: a prospective vulnerable plaque model? |
| Q31152970 | Selective inhibition of PI3K/Akt/mTOR signaling pathway regulates autophagy of macrophage and vulnerability of atherosclerotic plaque |
| Q28595661 | Senescent intimal foam cells are deleterious at all stages of atherosclerosis |
| Q37061136 | Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner |
| Q35629011 | Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines |
| Q38924331 | Syndecan-1 modulates the motility and resolution responses of macrophages |
| Q58691736 | Targeted Treatments for Restenosis and Vein Graft Disease |
| Q38985960 | Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease |
| Q37729656 | Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice |
| Q34289373 | The Fat‐Fed Apolipoprotein E Knockout Mouse Brachiocephalic Artery in the Study of Atherosclerotic Plaque Rupture |
| Q48350830 | The effect of zirconium doping of cerium dioxide nanoparticles on pulmonary and cardiovascular toxicity and biodistribution in mice after inhalation. |
| Q47386416 | The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage |
| Q37960811 | The role of complement in the development and manifestation of murine atherogenic inflammation: novel avenues. |
| Q35898043 | Toll-Like Receptor 9 Inactivation Alleviated Atherosclerotic Progression and Inhibited Macrophage Polarized to M1 Phenotype in ApoE-/- Mice |
| Q91451837 | Towards Quantification of Inflammation in Atherosclerotic Plaque in the Clinic - Characterization and Optimization of Fluorine-19 MRI in Mice at 3 T |
| Q35542584 | Towards understanding acute destabilization of vulnerable atherosclerotic plaques |
| Q43267508 | Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy |
Search more.